BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 51 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,491,929 | -1.5% | 9,582,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $9,632,880 | +5.0% | 9,582,000 | +8.9% | 0.00% | 0.0% |
| Q1 2023 | $9,178,488 | -2.9% | 8,800,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $9,456,128 | +40.0% | 8,800,000 | +29.4% | 0.00% | +50.0% |
| Q3 2022 | $6,753,000 | +13.2% | 6,800,000 | +13.3% | 0.00% | 0.0% |
| Q2 2022 | $5,963,000 | +32.3% | 6,000,000 | +33.3% | 0.00% | +100.0% |
| Q1 2022 | $4,506,000 | – | 4,500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 50,586 | $50,777,000 | 3.39% |
| MACKAY SHIELDS LLC | 76,920,000 | $76,828,000 | 1.86% |
| Sonora Investment Management Group, LLC | 8,300,000 | $8,336,000 | 0.79% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 37,527,000 | $37,482,000 | 0.66% |
| LOOMIS SAYLES & CO L P | 2,274,521 | $188,489,000 | 0.35% |
| Allianz Asset Management GmbH | 118,270,000 | $118,591,000 | 0.11% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,143,000 | $3,141,000 | 0.08% |
| THRIVENT FINANCIAL FOR LUTHERANS | 14,900,000 | $14,807,000 | 0.04% |
| Jefferies Group LLC | 2,848,000 | $2,831,408 | 0.02% |
| FORESIGHT CAPITAL MANAGEMENT ADVISORS, INC. | 14,000 | $14,000 | 0.02% |